Immediate Impact
5 from Science/Nature 55 standout
Citing Papers
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension
2023 Standout
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
2021 Standout
Works of G. Enia being referenced
Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease
2013
The MAURO study: Multiple Intervention and Audit in Renal Diseases to Optimize Care
2008
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| G. Enia | 587 | 238 | 256 | 39 | 961 | |
| Simona Hogaş | 519 | 219 | 404 | 41 | 972 | |
| Vincenzo Panuccio | 538 | 292 | 267 | 47 | 1.1k | |
| Laura Rosales | 701 | 88 | 321 | 33 | 1.1k | |
| Ali İhsan Günal | 532 | 216 | 349 | 43 | 1.0k | |
| Hyung Jik Kim | 424 | 133 | 152 | 49 | 953 | |
| Mohamed Tarek Eldehni | 576 | 229 | 250 | 23 | 892 | |
| J. Plüm | 877 | 172 | 413 | 57 | 1.2k | |
| Jer‐Chia Tsai | 478 | 316 | 193 | 38 | 1.0k | |
| Jwa-Kyung Kim | 450 | 149 | 175 | 66 | 991 | |
| Maria V. DeVita | 451 | 135 | 232 | 50 | 1.1k |
All Works
Loading papers...